Expedited partner therapy for sexually transmitted diseases: Editorial commentary

Clinical Infectious Diseases

Volumn 41, Issue 5, 2005, Pages 630-633

  Golden, Matthew R ^a,b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; CEFIXIME; CIPROFLOXACIN;

CHLAMYDIA TRACHOMATIS; CHLAMYDIASIS; CLINICAL TRIAL; EXPEDITED PARTNER THERAPY; GONORRHEA; HEALTH PROGRAM; HUMAN; INFECTION CONTROL; NEISSERIA GONORRHOEAE; NOTE; PATIENT DELIVERED PARTNER THERAPY; PRACTICE GUIDELINE; PREVALENCE; PRIORITY JOURNAL; PUBLIC HEALTH; SEXUAL BEHAVIOR; SEXUALLY TRANSMITTED DISEASE; VIRUS TRANSMISSION;

ANTI-INFECTIVE AGENTS; CONTACT TRACING; HUMANS; SEXUAL PARTNERS; SEXUALLY TRANSMITTED DISEASES;

EID: 23844465522     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/432479     Document Type: Note

References (32)

1. Kissinger P, Richardson-Alston G, Leichliter J, et al. Patient-delivered partner treatment for male urethritis: a randomized, controlled trial. Clin Infect Dis 2005; 41:623-9 (in this issue).
2. Groseclose SL, Zaidi AA, DeLisle SJ, Levine WC, St Louis ME. Estimated incidence and prevalence of genital Chlamydia trachomatis infections in the United States, 1996. Sex Transm Dis 1999; 26:339-44.
3. Fox KK, Whittington WL, Levine WC, Moran JS, Zaidi AA, Nakashima AK. Gonorrhea in the United States, 1981-1996: demographic and geographic trends. Sex Transm Dis 1998; 25:386-93.
4. Brown ST, Wiesner PJ. Problems and approaches to the control and surveillance of sexually transmitted agents associated with pelvic inflammatory disease in the United States. Am J Obstet Gynecol 1980; 138:1096-100.
5. Hillis SD, Nakashima A, Amsterdam L, et al. The impact of a comprehensive chlamydia prevention program in Wisconsin. Fam Plann Perspect 1995; 27:108-11.
6. Mertz KJ, Levine WC, Mosure DJ, Berman SM, Dorian KJ. Trends in the prevalence of chlamydial infections: the impact of community-wide testing. Sex Transm Dis 1997; 24:169-75.
7. Centers for Disease Control and Prevention (CDC). Sexually transmitted disease surveillance 2003. Atlanta: CDC, 2004.
8. Parran T. Shadow on the land: syphilis. New York: Reynal & Hitchcock, 1937.
9. Katz BP, Danos CS, Quinn TS, Caine V, Jones RB. Efficiency and cost-effectiveness of field follow-up for patients with Chlamydia trachomatis infection in a sexually transmitted diseases clinic. Sex Transm Dis 1988; 15:11-6.
10. Cleveland JQ. A cost-effective study of alternative methods for gonorrhea contact referral and rescreening. Dade County, FL: Dade County Department of Public Health.
11. Hethcote H, York J. Gonorrhea transmission dynamics and control. Lecture Notes in Biomathematics 1984; 56:1-105.
12. Kretzschmar M, van Duynhoven YT, Severijnen AJ. Modeling prevention strategies for gonorrhea and chlamydia using stochastic network simulations. Am J Epidemiol 1996; 144:306-17.
13. Golden MR, Hogben M, Handsfield HH, St Lawrence JS, Potterat JJ, Holmes KK. Partner notification for HIV and STD in the United States: low coverage for gonorrhea, chlamydial infection, and HIV. Sex Transm Dis 2003; 30:490-6.
14. Golden MR, Hogben M, Potterat JJ, Handsfield HH. HIV partner notification in the United States: a national survey of program coverage and outcomes. Sex Transm Dis 2004; 31:709-12.
15. Golden MR, Whittington WL, Gorbach PM, Coronado N, Boyd MA, Holmes KK. Partner notification for chlamydial infections among private sector clinicians in Seattle-King County: a clinician and patient survey. Sex Transm Dis 1999; 26:543-7.
16. St Lawrence JS, Montano DE, Kasprzyk D, Phillips WR, Armstrong K, Leichliter JS. STD screening, testing, case reporting, and clinical and partner notification practices: a national survey of US physicians. Am J Public Health 2002; 92:1784-8.
17. Potterat JJ, Rothenberg R. The case-finding effectiveness of self-referral system for gonorrhea: a preliminary report. Am J Public Health 1977; 67:174-6.
18. Woodhouse DE, Potterat JJ, Muth JB, Pratts CI, Rothenberg RB, Fogle JS. A civilian-military partnership to reduce the incidence of gonorrhea. Public Health Rep 1985; 100:61-5.
19. Patel HC, Viswalingam ND, Goh BT. Chlamydial ocular infection: efficacy of partner notification by patient referral. Int J STD AIDS 1994; 5:244-7.
20. Oh MK, Boker JR, Genuardi FJ, Cloud GA, Reynolds J, Hodgens JB. Sexual contact tracing outcome in adolescent chlamydial and gonococcal cervicitis cases. J Adolesc Health 1996; 18:4-9.
21. Fortenberry JD, Brizendine EJ, Katz BP, Orr DP. The role of self-efficacy and relationship quality in partner notification by adolescents with sexually transmitted infections. Arch Pediatr Adolesc Med 2002; 156:1133-7.
22. van de Laar MJ, Termorshuizen F, van den Hoek A. Partner referral by patients with gonorrhea and chlamydial infection: case-finding observations. Sex Transm Dis 1997; 24:334-42.
23. Institute of Medicine Committee on Prevention and Control of Sexually Transmitted Diseases, Eng TR, Butler WT. The hidden epidemic: confronting sexually transmitted diseases. Washington, DC: National Academy Press, 1997.
24. Hogben M, McCree DH, Golden MR. Patient-delivered partner therapy for sexually transmitted diseases as practiced by US physicians. Sex Transm Dis 2005; 32:101-5.
25. Niccolai LM, Winston DM. Physicians' opinions on partner management for nonviral sexually transmitted infections. Am J Prev Med 2005; 28:229-33.
26. Ramstedt K, Forssman L, Johannisson G. Contact tracing in the control of genital Chlamydia trachomatis infection. Int J STD AIDS 1991; 2:116-8.
27. Kissinger P, Brown R, Reed K, et al. Effectiveness of patient delivered partner medication for preventing recurrent Chlamydia trachomatis. Sex Transm Infect 1998; 74:331-3.
28. Schillinger JA, Kissinger P, Calvet H, et al. Patient-delivered partner treatment with azithromycin to prevent repeated Chlamydia trachomatis infection among women: a randomized, controlled trial. Sex Transm Dis 2003; 30:49-56.
29. Golden MR, Whittington WL, Handsfield HH, et al. Effect of expedited treatment of sex partners on recurrent or persistent gonorrhea or chlamydial infection. N Engl J Med 2005; 352:676-85.
30. Stekler J, Bachmann L, Brotman RM, et al. Concurrent sexually transmitted infections (STIs) in sex partners of patients with selected STIs: implications for patient-delivered partner therapy. Clin Infect Dis 2005; 40:787-93.
31. Centers for Disease Control and Prevention (CDC). HIV/AIDS surveillance report, 2003. Vol. 15. Atlanta: CDC, 2004.
32. Golden MR, Anukam U, Williams DH, Handsfield HH. The legal status of patient delivered partner therapy for sexually transmitted infections in the United States: a national survey of state medical and pharmacy boards. Sex Transm Dis 2005; 32:112-4.